Literature DB >> 6987863

Lack of person-to-person transmission of enterotoxigenic Escherichia coli despite close contact.

M M Levine, M B Rennels, L Cisneros, T P Hughes, D R Nalin, C R Young.   

Abstract

The scanty epidemiologic evidence available suggests that enterotoxigenic Escherichia coli (ETEC) are usually spread by contaminated food and water vehicles; little is known of the risk of secondary spread by contact transmission. Studies carried out in a 22-bed isolation Ward at the U. of Maryland Hospital gave the opportunity to determine whether individuals excreting ETEC, with and without diarrhea, would transmit the pathogen to controls living in close contact. In one combined study, seven volunteers who had ingested 10(8) virulent ETEC (strain H10407), were housed day and night for two weeks with eight other volunterrs participating in an intranasal attenuated influenza vaccine study. In a second study, four persons ingesting 10(8) ETEC (strain 214-4) lived with 13 who were inoculated with intranasal influenza vaccine. The individuals in the E. coli and influenza groups were randomly mixed in bedrooms and shared bathrooms, dining and recreation areas of the ward. Seven persons who ingested ETEC developed diarrhea; all 11 excreted the pathogen (10(7)-10(9) organisms/gm or ml of stool), and 10 had significant rises in anti-O or antitoxin antibody. In contrast, no influenza vaccinees, despite close sharing of facilities, developed diarrhea, excreted ETEC or had rises in antibody to E. coli antigens. These data suggest that ETEC are not readily transmitted to healthy adults by direct person-to-person contact. Precautions to prevent contamination of shared food sources would appear to be the most rational intervention to avoid secondary cases of ETEC diarrhea.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987863     DOI: 10.1093/oxfordjournals.aje.a112906

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  18 in total

1.  Antibiotic resistance from food.

Authors:  D E Corpet
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

2.  Potential sources of enterotoxigenic Escherichia coli in homes of children with diarrhoea in Thailand.

Authors:  P Echeverria; D N Taylor; J Seriwatana; U Leksomboon; W Chaicumpa; C Tirapat; B Rowe
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

3.  Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans.

Authors:  M M Levine; P Ristaino; G Marley; C Smyth; S Knutton; E Boedeker; R Black; C Young; M L Clements; C Cheney
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

4.  Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.

Authors:  Clayton Harro; Subhra Chakraborty; Andrea Feller; Barbara DeNearing; Alicia Cage; Malathi Ram; Anna Lundgren; Ann-Mari Svennerholm; August L Bourgeois; Richard I Walker; David A Sack
Journal:  Clin Vaccine Immunol       Date:  2011-08-18

Review 5.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors.

Authors:  Andreas Reisner; Karen A Krogfelt; Bjarke M Klein; Ellen L Zechner; Søren Molin
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

7.  Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.

Authors:  T S Coster; M K Wolf; E R Hall; F J Cassels; D N Taylor; C T Liu; F C Trespalacios; A DeLorimier; D R Angleberger; C E McQueen
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

8.  Distribution of Enteroinvasive and Enterotoxigenic Escherichia coli Across Space and Time in Northwestern Ecuador.

Authors:  Darlene Bhavnani; Rosa de los Ángeles Bayas; Velma K Lopez; Lixin Zhang; Gabriel Trueba; Betsy Foxman; Carl Marrs; William Cevallos; Joseph N S Eisenberg
Journal:  Am J Trop Med Hyg       Date:  2015-12-07       Impact factor: 2.345

9.  Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.

Authors:  Subhra Chakraborty; Clayton Harro; Barbara DeNearing; Malathi Ram; Andrea Feller; Alicia Cage; Nicole Bauers; A Louis Bourgeois; Richard Walker; David A Sack
Journal:  Clin Vaccine Immunol       Date:  2015-11-18

Review 10.  Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines.

Authors:  Gregory M Glenn; David H Francis; E Michael Danielsen
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.